If Johnson & Johnson is a family company, I’m not sure if it’s a family I want to belong to. The latest black eye for the once stellar and highly respected American company is the recall of 157,000 surgical staples used to treat hemorrhoids. The Wall Street Journal reports malfunctions […]
Author: Cal Warriner
A new study reports on the likelihood of needing a second surgery after a hip replacement procedure for osteoarthritis, and the news is not good for men and younger seniors. Researchers from Brigham and Women’s Hospital in Boston analyzed data from 51,000 Medicare patients who received total hip replacements (THR) […]
Hip arthroplasty devices have been available in the U.S. for over 50 years with a variety of outcomes. An artificial hip medical device may be used to restore function of the joint, relieve pain or cure a disease or condition not responsive to a more conservative therapy. In May 2011, […]
The predictions are not good. According to the National Osteoporosis Foundation, a woman age 50 and over has about a 50 percent risk of suffering bone fracture. One quarter of them will be a fracture that affects the vertebrae. Healing from this type of injury also slows as one ages […]
A follow-up of patients who received hip replacement surgery by the National Joint Registry of England and Wales has researchers issuing an ominous warning – women are strongly urged to avoid the hip replacement procedure known as “resurfacing,” according to a published report in the British medical journal, The Lancet. […]
Compounding Pharmacies The controversy over the fungal meningitis outbreak that is traced to contaminated steroid injections has brought compounding pharmacies under the spotlight. This is not the first time. A compounding pharmacy mixes drugs for use by hospitals and clinics. Often they make up for a shortfall in drugs, as […]
Where, oh where does clinical trial data go? Earlier this year, the British Medical Journal (BMJ) wrote that a large proportion of evidence from human clinical trials goes missing while cherry-picked favorable data appears. According to the BMJ, fewer than half of the data from clinical trials run using National […]
You have to give it to Shirley Boles, 74 – she just doesn’t give up. Today concluded the third in a series of trials against drug giant, Merck, over the osteoporosis drug, Fosamax. Boles of Walton Beach, Florida, took the drug for nine years and developed jaw necrosis. On Tuesday, […]
In a white paper about hernia mesh, analyst Winifred S. Hayes of Hayes Consulting helps one client figure out how to save money and be more efficient with their mesh purchases. The problem has been that in the case of hernia mesh, hospitals buy from a number of vendors and […]
A new Danish study in the journal, Calcified Tissue International, finds that a lower dose of osteoporosis drugs, also known as bisphosphonates, may actually represent a greater risk by about 50 percent of acute myocardial infarction, or clogging of the coronary vessels, when compared to a higher dose. Researchers from […]
